Physician profile
Robert Kerley
NPI 1366280950
$17,438.52
in general payments reported to CMS, 2019-2025
6 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,618 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Travel and Lodging: $3,948 · Food and Beverage: $1,714 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $11,499.84 |
| Travel and Lodging | $3,947.65 |
| Food and Beverage | $1,714.34 |
| Education | $276.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,678.36 | 2024-2025 | Amplia Mri Quad Crt-D Surescan, Crome Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $4,062.85 | 2025 | Assurity, Tacticath, Aveir |
| Boston Scientific Corporation | $3,749.38 | 2024-2025 | General - Brady, Farapulse, Emblem Mri S-Icd |
| Philips North America LLC | $754.09 | 2025 | Igt Devices Undivided, Lm Undivided |
| Biosense Webster, INC. | $164.86 | 2025 | Nuvision Ice Catheter, Carto 3 |
| Cardiva Medical, INC. | $28.98 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kerley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.